Mr Paul Thorning
Paul is Director of Open Innovation at the University of Bradford, and is a co-founder of the UK-China Healthtech Open Innovation programme. Key themes within this programme include Chinese and UK counterparts working together in the development of novel therapeutics, biomaterials, drug delivery and diagnostic technologies, and in the modernisation of traditional Chinese medicine, with the ultimate aim of successful joint commercialisation in global markets. The programme also focuses on successful, mutually beneficial transfer of UK healthcare technologies to China, to partners as well as through the creation of new companies.
Paul has broad technical and commercial experience from the chemical and pharmaceutical industry, where he held engineering, research, product development and commercial roles to senior executive level. He spent three years as Director of a UN health programme for refugees in Tanzania, before moving to Bradford to take on the role as Director of the Institute for Pharmaceutical Innovation. Paul was the Department of Business Innovation and Skills China Focal Point for Health and Innovation. He is a member of the China-UK Financing Innovation Task Force, a forum established by the China and UK governments to promote co-operation and investment in technology innovation. He is also a co-founder and Chief Executive of Crystec Ltd, a pharmaceutical particle and crystal engineering company which has an R&D subsidiary in Tianjin, China. Paul is a board member of Medilink North.